Advances in Chronic Kidney Disease
Volume 15, Issue 2 , Pages 191-205, April 2008

Self-Efficacy and Self-Management Behaviors in Patients With Chronic Kidney Disease

Medical Education Institute Inc., Madison, WI; University of Miami, Miami, FL; and Center for Health Systems Research and Analysis, University of Wisconsin, Madison, WI

Although past research has examined self-management among patients with end-stage renal disease (ESRD), little is known about self-management in patients with chronic kidney disease (CKD). In this cross-sectional survey (no intervention), 174 patients with CKD (serum creatinine ≥1.7 mg/dL) completed self-reported measures of self-efficacy, physical and mental functioning, and self-management. The purpose of the study was to explore the association between patients' perceived self-efficacy and their self-management behaviors. Five types of self-management behaviors were measured: communication with caregivers, partnership in care, self-care, self-advocacy, and medication adherence. Controlling for other relevant variables including age, education, diabetic status, hypertension, serum creatinine, physical functioning, and mental health functioning, higher perceived self-efficacy scores were associated with increased communication, partnership, self-care, and medication-adherence behaviors. In this study, patients' perceived self-efficacy was a more consistent correlate of self-management behavior than were demographic or health characteristics. Because self-management has been associated with positive patient outcomes, fostering self-management by supporting patient self-efficacy may have long-term benefits.

Index Words: Self-management, Self-efficacy, Self-care, Self-advocacy, Medication adherence, Chronic kidney disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by an unrestricted educational grant by Amgen Inc. for the Life Options Rehabilitation Program.

PII: S1548-5595(08)00007-4

doi:10.1053/j.ackd.2008.01.006

Advances in Chronic Kidney Disease
Volume 15, Issue 2 , Pages 191-205, April 2008